Helping to End Addiction Long-Term Initiative by NIH Launched to Address Opioid Epidemic
National Institutes of Health Director, Francis Collins, MD, PhD, announced on April 4, 2018 the launch of the Helping to End Addiction Long-Term Initiative.
National Institutes of Health Director, Francis Collins, MD, PhD, announced on April 4, 2018 the launch of the Helping to End Addiction Long-Term Initiative.
In a press release issued November 30, 2017, the US Food and Drug Administration announced it has approved Sublocade, a once-monthly buprenorphine injection for moderate to severe opioid use disorder.
Only a small percentage of adolescents undergoing treatment for severe opioid use disorders are receiving medication therapy to manage their condition.